SELB : Insider Transactions for Selecta Biosciences Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Selecta Biosciences Inc (SELB)

$0.50 0.00 (0.00%) as of 4:30 Thu 4/4

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

108,030,000

Market Cap:

54.46(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.4901 - $1.4

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Selecta Biosciences is a clinical-stage biopharmaceutical company. Co.'s ImmTOR® platform encapsulates rapamycin, also known as sirolimus, a Food and Drug Administration approved immunomodulator, in biodegradable nanoparticles ImmTOR is designed to induce antigen-specific immune tolerance. By combining ImmTOR with antigens of interest, Co.'s immune tolerance platform restores self-tolerance to auto-antigens in autoimmune diseases, amplify the ability of biologics (including gene therapies) and mitigate the formation of anti-drug antibodies against biologic drugs.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	1,222,516	1,223,316	1,223,316	1,403,316
Total Buy Value	$688,511	$689,063	$689,063	$877,582
Total People Bought	1	1	1	3
Total Buy Transactions	12	13	13	15
Total Shares Sold	0	0	3,637	15,619
Total Sell Value	$0	$0	$3,855	$23,149
Total People Sold	0	0	2	2
Total Sell Transactions	0	0	2	5
End Date	2024-02-01	2023-10-31	2023-05-02	2022-05-02

Adjust Filter Settings

Records found: 258

Page 8 of 11

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Medical Officer

• – –

2017-11-17

4

B

$10.26

$76,967

D/D

7,500

7,500

2.74

-

Springer Timothy A

Director

– • –

2017-11-14

4

B

$9.27

$534,095

D/D

57,598

461,349

2.39

-

GC, CCO & Corporate Secretary

• – –

2017-11-14

4

B

$9.25

$49,996

D/D

5,405

5,405

2.74

-

Cautreels Werner

President and CEO

• • –

2017-11-13

4

B

$9.31

$186,250

D/D

20,000

321,203

2.81

-

Springer Timothy A

Director

– • –

2017-11-10

4

B

$9.03

$42,906

I/I

4,752

9,752

2.1

-

Barabe Timothy C

Director

– • –

2017-11-10

4

B

$9.00

$22,505

D/D

2,500

7,492

2.39

-

Springer Timothy A

Director

– • –

2017-11-10

4

B

$9.03

$238,097

D/D

26,338

403,751

2.39

-

Barabe Timothy C

Director

– • –

2017-11-09

4

B

$9.73

$24,335

D/D

2,500

4,992

2.39

-

Springer Timothy A

Director

– • –

2017-11-09

4

B

$9.33

$46,681

I/I

5,000

5,000

2.1

-

Springer Timothy A

Director

– • –

2017-11-09

4

B

$9.33

$205,659

D/D

22,000

377,413

2.39

-

Director

– • –

2017-09-26

4

S

$18.91

$1,328,079

I/I

(70,226)

1,550,478

-

Director

– • –

2017-09-25

4

S

$18.99

$705,883

I/I

(37,175)

1,618,242

-

Director

– • –

2017-09-22

4

S

$19.26

$809,781

I/I

(42,036)

1,654,114

-

Director

– • –

2017-09-21

4

S

$19.86

$2,076,826

I/I

(104,577)

1,694,676

-

CFO and Treasurer

• – –

2017-09-20

4

AS

$20.00

$328,480

D/D

(16,424)

0

-

CFO and Treasurer

• – –

2017-09-20

4

OE

$0.63

$10,347

D/D

16,424

14,230

-

Director

– • –

2017-09-20

4

S

$20.03

$853,389

I/I

(42,610)

1,795,587

-

Johnston Lloyd P.

COO and SVP, R*D

• – –

2017-07-03

4

AS

$19.09

$113,806

D/D

(5,959)

1,606

-

Johnston Lloyd P.

COO and SVP, R*D

• – –

2017-07-03

4

OE

$2.77

$16,506

D/D

5,959

7,565

-

Chief Financial Officer

• – –

2017-06-29

4

AS

$20.00

$193,042

D/D

(9,652)

0

-

Chief Financial Officer

• – –

2017-06-29

4

OE

$0.47

$5,443

D/D

9,616

9,652

-

Chief Business Officer

• – –

2017-06-27

4

S

$19.30

$88,681

D/D

(4,595)

405

-

Chief Business Officer

• – –

2017-06-27

4

OE

$0.63

$2,895

D/D

4,595

5,000

-

Springer Timothy A

Director

– • –

2017-06-27

4

B

$17.71

$5,999,989

D/D

338,791

355,413

2.39

-

Chief Financial Officer

• – –

2017-06-26

4

S

$20.00

$137,720

D/D

(6,886)

36

-

258 Records found	1 2 3 4 5 6 7 8 9 Next	Page 8 of 11

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.